Data as of Friday, October 23, 2026From 500 companies’ SEC filings · refreshed twice a day · Send feedback
Companies / Health Care / Managed Health Care

Elevance Health stock buybacks

ELV
$2.2Bbought back in the 12 months to Sep 30, 2026

Elevance Health bought back $2.2B of its stock in the last twelve months, $1.9B more than it paid out in stock compensation. Its share count is down 2.7% from a year earlier.

Stock repurchases by quarter
$0$1B$2BQ4 '20Q4 '21Q4 '22Q4 '23Q4 '24Q3 '26
Show as table
PeriodValue
Q4 '20$1.4B
Q1 '21$447M
Q2 '21$480M
Q3 '21$451M
Q4 '21$522M
Q1 '22$545M
Q2 '22$624M
Q3 '22$579M
Q4 '22$568M
Q1 '23$622M
Q2 '23$646M
Q3 '23$480M
Q4 '23$928M
Q1 '24$566M
Q2 '24$463M
Q3 '24$60M
Q4 '24$1.8B
Q1 '25$880M
Q2 '25$378M
Q3 '25$876M
Q4 '25$471M
Q1 '26$1.1B
Q2 '26$234M
Q3 '26$330M
Diluted shares outstanding
219.1M234.4M249.7MQ4 '20Q4 '21Q4 '22Q4 '23Q4 '24Q4 '25Q3 '26
Show as table
PeriodValue
Q4 '20251.2M
Q1 '21248.2M
Q2 '21247.4M
Q3 '21246.0M
Q4 '21245.6M
Q1 '22244.4M
Q2 '22243.4M
Q3 '22242.2M
Q4 '22241.2M
Q1 '23239.7M
Q2 '23237.8M
Q3 '23236.5M
Q4 '23235.6M
Q1 '24234.2M
Q2 '24233.4M
Q3 '24233.1M
Q4 '24230.9M
Q1 '25227.2M
Q2 '25225.8M
Q3 '25223.7M
Q4 '25221.7M
Q1 '26220.4M
Q2 '26217.9M
Q3 '26217.6M
$330Mlast quarter (Q3 2026)
$1.9Bnet of stock compensation ($240M)
−2.7%diluted shares, 1 year
−11.7%diluted shares, 5 years
$1.5Bdividends, 12 months
33%of free cash flow ($6.5B) spent on buybacks
$0raised by issuing stock, 12 months
$5.0Bleft under its authorization as of Sep 30, 2026

By fiscal year

Fiscal yearBuybacksDividendsStock payFree cash flowDiluted sharesFiling
2025$2.6B$1.5B$276M$3.2B224.6M10-K
2024$2.9B$1.5B$191M$4.6B232.9M10-K
2023$2.7B$1.4B$289M$6.8B237.4M10-K
2022$2.3B$1.2B$264M$7.2B242.8M10-K
2021$1.9B$1.1B$255M$7.3B246.8M10-K
2020$2.7B$954M$283M$9.7B254.3M10-Q
2019$1.7B$818M$294M$5.0B260.3M10-K
2018$1.7B$776M$226M$2.6B264.2M10-K
2017$2.0B$705M$170M$3.4B267.8M10-K
2016$0$684M$165M$2.7B268.1M10-K

Questions

Does Elevance Health buy back its stock?
Elevance Health bought back $2.2B of its stock in the last twelve months, $1.9B more than it paid out in stock compensation. Its share count is down 2.7% from a year earlier.
How much did Elevance Health spend on buybacks in fiscal 2025?
$2.6B, according to its 10-K for the fiscal year ending Dec 31, 2025.
Is Elevance Health's share count going down?
Its diluted share count changed −11.7% over five fiscal years and −2.7% over the last year.
Does Elevance Health have a buyback authorization?
Its filings show $5.0B remaining under its repurchase authorization as of Sep 30, 2026.

Latest filing used: 10-Q for the period ending Sep 30, 2026, filed Oct 21, 2026 · open on SEC.gov

Other Health Care companies